[go: up one dir, main page]

WO2012007783A8 - Kits and methods for detecting the ability to induce an immunogenic cancer cell death in a subject - Google Patents

Kits and methods for detecting the ability to induce an immunogenic cancer cell death in a subject Download PDF

Info

Publication number
WO2012007783A8
WO2012007783A8 PCT/IB2010/002034 IB2010002034W WO2012007783A8 WO 2012007783 A8 WO2012007783 A8 WO 2012007783A8 IB 2010002034 W IB2010002034 W IB 2010002034W WO 2012007783 A8 WO2012007783 A8 WO 2012007783A8
Authority
WO
WIPO (PCT)
Prior art keywords
subject
cancer
treatment
induce
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2010/002034
Other languages
French (fr)
Other versions
WO2012007783A1 (en
Inventor
Laurence Zitvogel
Guido Kroemer
Nicolas Delahaye
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Gustave Roussy (IGR)
Original Assignee
Institut Gustave Roussy (IGR)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Gustave Roussy (IGR) filed Critical Institut Gustave Roussy (IGR)
Priority to PCT/IB2010/002034 priority Critical patent/WO2012007783A1/en
Priority to EP20110713731 priority patent/EP2561088A1/en
Priority to US13/642,221 priority patent/US8828944B2/en
Priority to EP14165240.4A priority patent/EP2806034B1/en
Priority to PCT/EP2011/055134 priority patent/WO2011131472A1/en
Publication of WO2012007783A1 publication Critical patent/WO2012007783A1/en
Anticipated expiration legal-status Critical
Priority to US13/772,944 priority patent/US8865653B2/en
Publication of WO2012007783A8 publication Critical patent/WO2012007783A8/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to the fields of genetics, immunology and medicine. The present invention more specifically relates to in vitro or ex vivo methods for determining the susceptibility to a cancer treatment of a subject having a tumour. These methods comprise a step of determining the ability of the treatment, of the subject and/or of the tumour to induce an anticancer immune response, the inability of at least one of the treatment, the subject and the tumor to induce an anticancer immune response being indicative of a resistance of the subject to the therapeutic treatment of cancer. Inventors in particular identify genes specific of a human subject or of cancerous cells which can be used to predict or assess the sensitivity of a subject to a treatment of cancer. The invention also relates to particular compounds capable of activating or enhancing the immune system of a particular subject, when the subject is exposed to a therapeutic treatment of cancer or before such an exposition. It further relates to uses of such compounds, in particular to prepare a pharmaceutical composition to allow or improve the efficiency of a therapy of cancer in a subject in need thereof. The present invention in addition provides kits, methods for selecting a compound of interest, as well as pharmaceutical compositions and uses thereof.
PCT/IB2010/002034 2010-04-22 2010-07-13 Kits and methods for detecting the ability to induce an immunogenic cancer cell death in a subject Ceased WO2012007783A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PCT/IB2010/002034 WO2012007783A1 (en) 2010-07-13 2010-07-13 Kits and methods for detecting the ability to induce an immunogenic cancer cell death in a subject
EP20110713731 EP2561088A1 (en) 2010-04-22 2011-04-01 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
US13/642,221 US8828944B2 (en) 2010-04-22 2011-04-01 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
EP14165240.4A EP2806034B1 (en) 2010-04-22 2011-04-01 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
PCT/EP2011/055134 WO2011131472A1 (en) 2010-04-22 2011-04-01 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
US13/772,944 US8865653B2 (en) 2010-04-22 2013-02-21 Method of treatment for immunogenic treatment resistant cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2010/002034 WO2012007783A1 (en) 2010-07-13 2010-07-13 Kits and methods for detecting the ability to induce an immunogenic cancer cell death in a subject

Publications (2)

Publication Number Publication Date
WO2012007783A1 WO2012007783A1 (en) 2012-01-19
WO2012007783A8 true WO2012007783A8 (en) 2013-07-25

Family

ID=43479616

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2010/002034 Ceased WO2012007783A1 (en) 2010-04-22 2010-07-13 Kits and methods for detecting the ability to induce an immunogenic cancer cell death in a subject

Country Status (1)

Country Link
WO (1) WO2012007783A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8975087B2 (en) 2010-11-24 2015-03-10 Inanovate, Inc. Longitudinal assay
WO2014018801A1 (en) * 2012-07-25 2014-01-30 The Texas A&M University System Diagnosis and treatment of cancer using differentially expressed starvation markers
WO2014150869A1 (en) * 2013-03-15 2014-09-25 Inanovate, Inc. Cartridge device for processing time-resolved assays
WO2014150853A1 (en) * 2013-03-15 2014-09-25 Inanovate, Inc. Analyte measurement using longitudinal assay
WO2014150860A1 (en) * 2013-03-15 2014-09-25 Inanovate, Inc. Analysis methods of time-resolved assay data
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
EP3521454A1 (en) 2014-05-09 2019-08-07 LifeCodexx AG Detection of dna that originates from a specific cell-type and related methods
DK3221363T3 (en) 2014-11-21 2020-08-10 Bristol Myers Squibb Co ANTIBODIES TO CD73 AND USES THEREOF
HRP20201756T8 (en) 2014-11-21 2021-08-20 Bristol-Myers Squibb Company Antibodies comprising modified heavy constant regions
DK3168309T3 (en) * 2015-11-10 2020-06-22 Eurofins Lifecodexx Gmbh DETECTION OF Fetal Chromosomal Aneuploidies Using DNA Regions With Different Methylation Between Foster And The Pregnant Female
CN107312837A (en) * 2017-06-26 2017-11-03 广州医科大学 A kind of primer sets of detection rs2066853 loci gene types and its detection kit and application

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US90917A (en) 1869-06-08 Improved mode of forming the connections of gas-purifiers
CA2468312A1 (en) * 2001-11-28 2003-06-05 Dnaprint Genomics, Inc. Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness
MX2007007401A (en) * 2004-12-17 2007-10-08 Johnson & Johnson Methods for assessing patients with acute myeloid leukemia.
WO2006133399A1 (en) * 2005-06-08 2006-12-14 Hitachi Chemical Research Center, Inc. METHOD FOR PREDICTING IMMUNE RESPONSE TO NEOPLASTIC DISEASE BASED ON mRNA EXPRESSION PROFILE IN NEOPLASTIC CELLS AND STIMULATED LEUKOCYTES
US8263344B2 (en) 2006-09-08 2012-09-11 Institut Gustave Roussy Compounds regulating calreticulin, KDEL receptor and/or Erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment
US20090131268A1 (en) * 2007-09-14 2009-05-21 Affymetrix, Inc. Methods for Genotyping Polymorphisms
EP2227780A4 (en) * 2008-03-19 2011-08-03 Existence Genetics Llc Genetic analysis
GB0805312D0 (en) * 2008-03-20 2008-04-30 Medical Res Council Modulation of the immune response

Also Published As

Publication number Publication date
WO2012007783A1 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
WO2012007783A8 (en) Kits and methods for detecting the ability to induce an immunogenic cancer cell death in a subject
WO2012174256A3 (en) Dna methylation profiles in cancer
NZ704295A (en) Compositions and methods for the treatment of infections and tumors
BR112012018132A2 (en) "Tumor stem cell markers and their use".
ZA201604468B (en) Analysis of genomic dna, rna, and proteins in exosomes for diagnosis and theranosis
WO2014004990A3 (en) Methods for determining drug efficacy using cereblon-associated proteins
WO2014026768A8 (en) Colorectal cancer markers
PH12015501092A1 (en) Anti-ceacam5 antibodies and uses thereof
WO2010081001A3 (en) Recurrent gene fusions in cancer
EP4435112A3 (en) Compositions and methods for screening solid tumors
EP2373794A4 (en) Nectin-4 for target genes of cancer therapy and diagnosis
WO2014127917A8 (en) Combination of vaccination and inhibition of the pd-1 pathway
WO2012006421A3 (en) Diagnosis and treatment of breast cancer
WO2011034906A3 (en) Recurrent gene fusions in prostate cancer
MX2015001716A (en) Niclosamide and its derivatives for use in the treatment of solid tumors.
WO2013089882A3 (en) Recurrent gene fusions in breast cancer
WO2013025952A3 (en) Methods and compositions for the treatment and diagnosis of breast cancer
WO2014057357A3 (en) Method for the diagnosis, prognosis and treatment of prostate cancer metastasis using c-maf
WO2012158780A3 (en) Lung cancer signature
WO2011109224A8 (en) Gene sets for detection ultraviolet a exposure and methods of use thereof
WO2012143481A3 (en) Prostate cancer markers
WO2008088860A3 (en) Polymorphisms in the egfr pathway as markers for cancer treatment
WO2011123678A3 (en) Substituted benzo-pyrido-triazolo-diazepine compounds
WO2012028679A3 (en) Prognostic and/or predictive biomarkers and biological applications thereof
EP2329044A4 (en) Prmt1 for target genes of cancer therapy and diagnosis

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE